New studies indicate that Lecanemab , a experimental drug, could reduce the development of mild cognitive decline. This medication focuses on removing amyloid plaques from the central nervous https://umarkpbq321025.aboutyoublog.com/51939165/donanemab-an-potential-innovative-cognitive-approach